Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
China
· Delayed Price · Currency is CNY 42.60
-0.30 (-0.70%)
Mar 10, 2026, 9:25 AM CST
SHE:300255 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 39,152 | 18,372 | 11,957 | 5,036 | 7,472 | 5,693 | Upgrade
|
| Market Cap Growth | 126.72% | 53.65% | 137.41% | -32.59% | 31.26% | 11.92% | Upgrade
|
| Enterprise Value | 41,453 | 20,352 | 14,091 | 6,817 | 8,617 | 6,631 | Upgrade
|
| Last Close Price | 42.60 | 19.99 | 13.01 | 5.47 | 8.09 | 6.15 | Upgrade
|
| PE Ratio | - | - | - | 287.58 | 31.99 | 22.52 | Upgrade
|
| Forward PE | - | 12.44 | 12.44 | 12.44 | 12.44 | 12.44 | Upgrade
|
| PS Ratio | 42.19 | 17.82 | 8.48 | 2.16 | 2.52 | 2.41 | Upgrade
|
| PB Ratio | 26.48 | 11.96 | 6.64 | 1.65 | 2.43 | 2.00 | Upgrade
|
| P/TBV Ratio | 32.28 | 14.65 | 8.02 | 1.80 | 2.68 | 2.20 | Upgrade
|
| P/OCF Ratio | 811.91 | 326.80 | 354.53 | 1611.41 | 2602.11 | - | Upgrade
|
| EV/Sales Ratio | 44.67 | 19.74 | 9.99 | 2.92 | 2.90 | 2.81 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | 41.33 | 22.68 | 15.64 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 63.13 | 26.59 | 17.98 | Upgrade
|
| EV/FCF Ratio | -284.90 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 1.75 | 1.66 | 1.32 | 0.82 | 0.57 | 0.47 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | 15.10 | 4.58 | 3.14 | Upgrade
|
| Net Debt / Equity Ratio | 1.58 | 1.50 | 1.19 | 0.55 | 0.39 | 0.30 | Upgrade
|
| Net Debt / EBITDA Ratio | -19.16 | -21.58 | -1.99 | 10.26 | 3.15 | 2.01 | Upgrade
|
| Net Debt / FCF Ratio | -16.08 | -12.57 | -10.39 | -3.95 | -3.92 | -2.22 | Upgrade
|
| Asset Turnover | 0.20 | 0.23 | 0.27 | 0.42 | 0.61 | 0.56 | Upgrade
|
| Inventory Turnover | 0.62 | 0.62 | 0.85 | 0.56 | 0.60 | 0.45 | Upgrade
|
| Quick Ratio | 0.24 | 0.25 | 0.29 | 0.72 | 0.52 | 0.67 | Upgrade
|
| Current Ratio | 0.87 | 0.91 | 1.19 | 2.18 | 1.97 | 2.12 | Upgrade
|
| Return on Equity (ROE) | -18.04% | -15.83% | -51.43% | 0.33% | 7.81% | 9.01% | Upgrade
|
| Return on Assets (ROA) | -2.57% | -2.45% | -13.46% | 1.20% | 4.15% | 5.41% | Upgrade
|
| Return on Invested Capital (ROIC) | -5.08% | -4.60% | -26.38% | 1.34% | 7.22% | 9.15% | Upgrade
|
| Return on Capital Employed (ROCE) | -8.50% | -7.70% | -42.80% | 2.50% | 9.40% | 11.70% | Upgrade
|
| Earnings Yield | -0.77% | -1.36% | -10.37% | 0.35% | 3.13% | 4.44% | Upgrade
|
| FCF Yield | -0.37% | -1.00% | -1.72% | -8.50% | -4.08% | -6.73% | Upgrade
|
| Dividend Yield | - | - | - | 0.09% | 0.32% | - | Upgrade
|
| Payout Ratio | - | - | - | 708.02% | 26.50% | 27.08% | Upgrade
|
| Buyback Yield / Dilution | -35.95% | -0.58% | -4.91% | 6.27% | 0.23% | 0.24% | Upgrade
|
| Total Shareholder Return | -35.95% | -0.58% | -4.91% | 6.37% | 0.55% | 0.24% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.